▲ Peaking
Business
New Parkinson’s drug approved in the US: What does it do differently?
US FDA approves first-in-class Parkinson's treatment, JUVMO, from AbbVie
2 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 2 separate news trends connected to Us Fda, spanning July 23, 2026 through September 28, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 26 article observations and 25 source signals, led by Business coverage. Use it to compare how individual events emerged, spread and changed over time.
US FDA approves first-in-class Parkinson's treatment, JUVMO, from AbbVie
A poultry firm is recalling nearly 1.6 million dozen eggs across the US due to potential salmonella contamination.